Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies
Head & Neck, 05/02/2012
Rosenberg L et al. – Chemoradiotherapy (CRT) for salivary gland malignancies has acceptable toxicity, CRT is proven beneficial for many other cancers, and some salivary gland malignancies are clinically responsive to chemotherapy. CRT, therefore, should be considered for treatment of high–risk salivary gland malignancies.



